MERSANA THERAPEUTICS INC (MRSN)
US59045L1061 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40K -95.18% | 26.58M 66,350.00% | 36.855M 38.66% | 32.382M -12.14% | 27.755M -14.29% | 49.508M 78.38% | 28.791M -41.85% | 187.77M 552.18% | 509.17M 171.17% | 762.28M 49.71% | 699.59M -8.22% | |
| EBITDA YoY % growth | -168M -92.88% | -202.84M -20.74% | -169.44M 16.47% | -76.906M 54.61% | -77.991M -1.41% | -94.119M -20.68% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -168.86M -91.65% | -203.77M -20.67% | -170.957M 16.10% | -80.16M 53.11% | -92.347M -15.20% | -110.727M -19.90% | -121.449M -9.68% | -18.91M 84.43% | 219.34M 1,259.93% | 345.72M 57.62% | 403.81M 16.80% | |
| Operating Margin | -422,150.00% | -766.63% | -463.86% | -247.54% | -332.72% | -223.66% | -421.83% | -10.07% | 43.08% | 45.35% | 57.72% | |
| EPS YoY % growth | -2.40 -67.83% | -2.19 8.75% | -1.42 35.16% | -0.61 56.74% | -0.59 4.28% | -0.72 -22.61% | -0.84 -16.02% | -0.31 63.41% | 1.17 483.33% | 2.40 104.35% | 2.91 21.28% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 3.24% | -0.19 -19.53% | -0.18 8.20% | -0.19 -106.83% | -0.18 -18.59% |
| Revenue Q2Q % growth | 7.793M -27.18% | 5.177M -44.00% | 5.177M 125.77% | 5.177M -58.91% | 5.177M -33.57% |
| EBITDA Q2Q % growth | -18.104M 6.73% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.45M 7.06% | -24.633M -17.29% | -25.653M -0.78% | -26.673M -121.00% | -27.183M -39.75% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 66.67% | -0.18 | 0.09 | 49.71% |
| Q2 2024 Q2Q % growth | -0.20 57.45% | -0.17 | -0.03 | -14.37% |
| Q1 2024 Q2Q % growth | -0.16 69.23% | -0.18 | 0.02 | 13.34% |
| Q4 2023 Q2Q % growth | -0.16 63.64% | -0.17 | 0.01 | 4.54% |
| Q3 2023 Q2Q % growth | -0.27 55.74% | -0.37 | 0.10 | 26.85% |
| Q2 2023 Q2Q % growth | -0.47 14.55% | -0.45 | -0.02 | -4.38% |
| Q1 2023 Q2Q % growth | -0.52 11.86% | -0.44 | -0.08 | -16.99% |
| Q4 2022 Q2Q % growth | -0.44 35.29% | -0.51 | 0.07 | 14.48% |
| Q3 2022 Q2Q % growth | -0.61 3.17% | -0.09 | -0.52 | -564.49% |
| Q2 2022 Q2Q % growth | -0.55 6.78% | -0.53 | -0.02 | -3.70% |
| Q1 2022 Q2Q % growth | -0.59 -18.00% | -0.32 | -0.27 | -81.57% |
| Q4 2021 Q2Q % growth | -0.68 -61.90% | -0.68 | 0.00 | 0.28% |
| Q3 2021 Q2Q % growth | -0.63 -90.91% | -0.59 | -0.04 | -6.49% |
| Q2 2021 Q2Q % growth | -0.59 -78.79% | -0.51 | -0.08 | -16.07% |
| Q1 2021 Q2Q % growth | -0.50 -42.86% | -0.40 | -0.10 | -24.10% |
| Q4 2020 Q2Q % growth | -0.42 -23.53% | -0.33 | -0.09 | -26.97% |
| Q3 2020 Q2Q % growth | -0.33 5.71% | -0.31 | -0.02 | -6.08% |
| Q2 2020 Q2Q % growth | -0.33 8.33% | -0.30 | -0.03 | -8.45% |
| Q1 2020 Q2Q % growth | -0.35 -150.00% | -0.38 | 0.03 | 7.97% |
| Q4 2019 Q2Q % growth | -0.34 | -0.39 | 0.05 | 12.66% |
| Q3 2019 Q2Q % growth | -0.35 | -0.38 | 0.03 | 8.09% |
| Q2 2019 Q2Q % growth | -0.36 | -0.39 | 0.03 | 7.93% |
| Q1 2019 Q2Q % growth | 0.70 | -0.03 | 0.73 | 2,845.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.598M 63.65% | 7.681M | 4.917M | 64.02% |
| Q2 2024 Q2Q % growth | 2.293M -78.48% | 8.896M | -6.603M | -74.22% |
| Q1 2024 Q2Q % growth | 9.245M 18.50% | 8.67M | 575K | 6.63% |
| Q4 2023 Q2Q % growth | 10.701M -27.15% | 15.068M | -4.367M | -28.98% |
| Q3 2023 Q2Q % growth | 7.698M 38.20% | 9.537M | -1.839M | -19.28% |
| Q2 2023 Q2Q % growth | 10.654M 148.93% | 13.214M | -2.56M | -19.37% |
| Q1 2023 Q2Q % growth | 7.802M 282.45% | 18.651M | -10.849M | -58.17% |
| Q4 2022 Q2Q % growth | 14.69M 146,800.00% | 15.589M | -899K | -5.77% |
| Q3 2022 Q2Q % growth | 5.57M 55,600.00% | 35.879M | -30.309M | -84.48% |
| Q2 2022 Q2Q % growth | 4.28M 42,700.00% | 2.246M | 2.034M | 90.56% |
| Q1 2022 Q2Q % growth | 2.04M 20,300.00% | 8.308M | -6.268M | -75.45% |
| Q4 2021 Q2Q % growth | 10K | 3.743K | 6.257K | 167.14% |
| Q3 2021 Q2Q % growth | 10K | 105.356K | -95.356K | -90.51% |
| Q2 2021 Q2Q % growth | 10K -98.75% | 144.503K | -134.503K | -93.08% |
| Q1 2021 Q2Q % growth | 10K | 326.4K | -316.4K | -96.94% |
| Q4 2020 Q2Q % growth | 10K -75.00% | 171.87K | -161.87K | -94.18% |
| Q3 2020 Q2Q % growth | 10K -98.81% | 447.984K | -437.984K | -97.77% |
| Q2 2020 Q2Q % growth | 800K 300.00% | 306K | 494K | 161.44% |
| Q1 2020 Q2Q % growth | 10K -99.98% | 399.503K | -389.503K | -97.50% |
| Q4 2019 Q2Q % growth | 40K | 297.503K | -257.503K | -86.55% |
| Q3 2019 Q2Q % growth | 840K | 297.503K | 542.497K | 182.35% |
| Q2 2019 Q2Q % growth | 200K | 756.503K | -556.503K | -73.56% |
| Q1 2019 Q2Q % growth | 41.04M | 21.016M | 20.024M | 95.28% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 17% | 0% | 15.31% |
| Revenue | 0% | -8.55% | 0% | 25.18% |